These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 6614416

  • 1. [Use of oral morphine in incurable pain].
    Twycross R, Zenz M.
    Anaesthesist; 1983 Jun; 32(6):279-83. PubMed ID: 6614416
    [Abstract] [Full Text] [Related]

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Jun; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 3. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 4. Oral opioids in the treatment of cancer pain.
    Zylicz Z, Twycross RG.
    Neth J Med; 1991 Aug; 39(1-2):108-14. PubMed ID: 1660107
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, crossover comparison between single-dose and double-dose immediate-release oral morphine at bedtime in cancer patients.
    Dale O, Piribauer M, Kaasa S, Moksnes K, Knobel H, Klepstad P.
    J Pain Symptom Manage; 2009 Jan; 37(1):68-76. PubMed ID: 18504090
    [Abstract] [Full Text] [Related]

  • 6. Intravenous morphine can avoid distressing constipation associated with oral morphine: a retrospective analysis of our experience in 11 patients in the palliative care in-patient unit.
    Mazumdar A, Mishra S, Bhatnagar S, Gupta D.
    Am J Hosp Palliat Care; 2008 Jan; 25(4):282-4. PubMed ID: 18768425
    [Abstract] [Full Text] [Related]

  • 7. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, Strasser F, Willey J, Bertolino M, Mathias C, Spruyt O, Fisch MJ.
    J Clin Oncol; 2004 Jan 01; 22(1):185-92. PubMed ID: 14701781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct 01; 17(97):179-82. PubMed ID: 19530373
    [Abstract] [Full Text] [Related]

  • 11. Low morphine doses in opioid-naive cancer patients with pain.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Ficorella C, Verna L, Tirelli W, Villari P, Arcuri E.
    J Pain Symptom Manage; 2006 Mar 01; 31(3):242-7. PubMed ID: 16563318
    [Abstract] [Full Text] [Related]

  • 12. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain.
    De Conno F, Ripamonti C, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, Arcuri E, Bertetto O, MERITO Study Group.
    Palliat Med; 2008 Apr 01; 22(3):214-21. PubMed ID: 18477715
    [Abstract] [Full Text] [Related]

  • 13. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R, Smit JM, Schipper RM, Wicks MA, Zuurmond WW.
    Curr Med Res Opin; 2003 Apr 01; 19(6):457-69. PubMed ID: 14594516
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries.
    Mahar PJ, Rana JA, Kennedy CS, Christopher NC.
    Pediatr Emerg Care; 2007 Aug 01; 23(8):544-8. PubMed ID: 17726413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of severe non-cancer pain by oral morphine].
    Kato Y, Kato A.
    Masui; 2008 Nov 01; 57(11):1343-50. PubMed ID: 19039960
    [Abstract] [Full Text] [Related]

  • 17. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan 01; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 18. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
    Miner JR, Moore J, Gray RO, Skinner L, Biros MH.
    Acad Emerg Med; 2008 Dec 01; 15(12):1234-40. PubMed ID: 18945240
    [Abstract] [Full Text] [Related]

  • 19. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S, Intravaia G, Villari P, Ferrera P, Riina S, David F, Mangione S.
    Clin J Pain; 2007 Dec 01; 23(9):793-8. PubMed ID: 18075407
    [Abstract] [Full Text] [Related]

  • 20. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C, Vara F.
    J Pain Palliat Care Pharmacother; 2005 Dec 01; 19(2):7-12. PubMed ID: 16061456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.